SNCA and Parkinson disease: This model is a highly physiological, slowly progressing mouse model of parkinsonism, that, in capturing a human disease-relevant genetic burden of α-synuclein overexpression, shows early deficits in DA release restricted to dorsal striatum prior to degeneration of DA neurons, disturbed encoding of behaviour of surviving DA neurons and a motor phenotype in old age32,47.